Provide first-in-class and best-in-class biological drugs

with affordable prices for global patients


Our complete product pipeline system relying on its own powerful and complete commercialization platforms, which integrates the research & development, manufacturing and sales, focuses on three major therapeutic areas,  cardiovascular diseases, oncology & autoimmune diseases , alimentary tract and metabolism, has a preferred product portfolio of 13 biological assets for sustained development.